-
1
-
-
0018330381
-
Cilioretinal arteries and retinal arterial occlusion
-
Brown GC, Shields JA. Cilioretinal arteries and retinal arterial occlusions. Arch Ophthalmol 1979; 97: 84-92. (Pubitemid 9051060)
-
(1979)
Archives of Ophthalmology
, vol.97
, Issue.1
, pp. 84-92
-
-
Brown, G.C.1
Shield, J.A.2
-
2
-
-
0024638883
-
Branch retinal-artery obstruction: A review of 2001 eyes
-
Ros MA, Magargal LE, Uram M. Branch retinal-artery obstruction: A review of 2001 eyes. Ann Ophthalmol 1989; 21: 103-7.
-
(1989)
Ann Ophthalmol
, vol.21
, pp. 103-107
-
-
Ros, M.A.1
Magargal, L.E.2
Uram, M.3
-
3
-
-
6344289580
-
Retinal artery obstruction
-
In: Ry an SJ, Schachat AP, Murphy RP, eds. 3rd ed. Vol 2. Medical retina. St Louis, Missouri: Mosby
-
Ry an SJ, Schachat AP, Murphy RP Sharma S, Brown GC. Retinal artery obstruction. In: Ry an SJ, Schachat AP, Murphy RP, eds. Retina, 3rd ed. Vol 2. Medical retina. St Louis, Missouri: Mosby, 2001: 1350-67.
-
(2001)
Retina
, pp. 1350-1367
-
-
Ry An, S.J.1
Schachat, A.P.2
Murphy, R.P.3
Sharma, S.4
Brown, G.C.5
-
4
-
-
34547700399
-
Bevacizumab in non small cell lung cancer
-
Sandler A. Bevacizumab in non small cell lung cancer. Clin Cancer Res 2007; 13: 4613-6.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 4613-4616
-
-
Sandler, A.1
-
5
-
-
33750296920
-
The International Intravitreal Bevacizumab Safety Survey: Using the internet to assess drug safety worldwide
-
DOI 10.1136/bjo.2006.099598
-
Fung AE, Rosenf eld PJ, Reichel E. The international intrav itreal bevacizumab safety survey : using the internet to assess drug safety worldwide. Br J Ophthalmol 2006; 90: 1344-9. (Pubitemid 44702055)
-
(2006)
British Journal of Ophthalmology
, vol.90
, Issue.11
, pp. 1344-1349
-
-
Fung, A.E.1
Rosenfeld, P.J.2
Reichel, E.3
-
6
-
-
34548141828
-
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
-
DOI 10.1093/jnci/djm086
-
Scappaticci FA, Skillings JR, Holden SN, et al. Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst 2007; 99: 1232-9. (Pubitemid 47299901)
-
(2007)
Journal of the National Cancer Institute
, vol.99
, Issue.16
, pp. 1232-1239
-
-
Scappaticci, F.A.1
Skillings, J.R.2
Holden, S.N.3
Gerber, H.-P.4
Miller, K.5
Kabbinavar, F.6
Bergsland, E.7
Ngai, J.8
Holmgren, E.9
Wang, J.10
Hurwitz, H.11
-
7
-
-
20144372969
-
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: Twelve-week results of an uncontrolled open-label clinical study
-
DOI 10.1016/j.ophtha.2005.02.007, PII S0161642005002976
-
Michels S, Rosenf eld PJ, Puliaf ito CA, et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration. Twelv e-week results of an uncontrolled open-label clinical study. Ophthalmology 2005; 112: 1035-47. (Pubitemid 40797459)
-
(2005)
Ophthalmology
, vol.112
, Issue.6
, pp. 1035-1047
-
-
Michels, S.1
Rosenfeld, P.J.2
Puliafito, C.A.3
Marcus, E.N.4
Venkatraman, A.S.5
-
8
-
-
34250359084
-
Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion
-
Vatav uk Z, Bencic G, Mandic Z. Intrav itreal bevacizumab for neovascular glaucoma following central retinal artery occlusion. Eur J Ophthalmol 2007; 17: 269-71. (Pubitemid 46918117)
-
(2007)
European Journal of Ophthalmology
, vol.17
, Issue.2
, pp. 269-271
-
-
Vatavuk, Z.1
Bencic, G.2
Mandic, Z.3
|